Martino M - Search Results

1

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.

Bruzzese A, Derudas D, Galli M, Martino EA, Rocco S, Conticello C, Califano C, Giuliani N, Mangiacavalli S, Farina G, Lombardo A, Brunori M, Rossi E, Antonioli E, Ria R, Zambello R, Di Renzo N, Mele G, Marcacci G, Pietrantuono G, Palumbo G, Cascavilla N, Cerchione C, Belotti A, Criscuolo C, Uccello G, Curci P, Vigna E, Mendicino F, Iaccino E, Mimmi S, Botta C, Vincelli D, Sgherza N, Bonalumi A, Cupelli L, Stocchi R, Martino M, Ballanti S, Gangemi D, Gagliardi A, Gamberi B, Pompa A, Tripepi G, Frigeri F, Consoli U, Bringhen S, Zamagni E, Patriarca F, De Stefano V, Di Raimondo F, Palmieri S, Petrucci MT, Offidani M, Musto P, Boccadoro M, Cavo M, Neri A, Morabito F, Gentile M. Bruzzese A, et al. Among authors: martino ea, martino m. Hematol Oncol. 2022 Oct;40(4):704-715. doi: 10.1002/hon.3031. Epub 2022 Jun 1. Hematol Oncol. 2022. PMID: 35608183 Free article.

2

Infectious complications in breast cancer patients undergoing peripheral blood stem cell transplantation: a single center retrospective analysis towards outpatient strategy.

Morabito F, Irrera G, Oliva E, Console G, Martino M, Pucci G, Messina G, Barbaro P, Palazzo S, Iacopino P. Morabito F, et al. Among authors: martino m. Bone Marrow Transplant. 2001 Nov;28(9):883-8. doi: 10.1038/sj.bmt.1703246. Bone Marrow Transplant. 2001. PMID: 11781650

3

Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myeloma.

Morabito F, Martino M, Stelitano C, Oliva E, Kropp M, Irrera G, Console G, Fujo M, Messina G, Molica S, Callea V, Iacopino P. Morabito F, et al. Among authors: martino m. Haematologica. 2002 Nov;87(11):1192-9. Haematologica. 2002. PMID: 12414350

4

Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients.

Galimberti S, Morabito F, Guerrini F, Palumbo GA, Azzará A, Martino M, Benedetti E, Di Raimondo F, Petrini M. Galimberti S, et al. Among authors: martino m. Br J Haematol. 2003 Feb;120(3):405-12. doi: 10.1046/j.1365-2141.2003.04106.x. Br J Haematol. 2003. PMID: 12580954 Free article.

5

High-dose chemotherapy with mitoxantrone + melphalan and autologous stem cell rescue in metastatic breast cancer patients: a study of feasibility and tolerability.

Martino M, Morabito F, Console G, Irrera G, Pucci G, Penna G, Dattola A, Callea I, Pontari A, Condemi A, Messina G, Nardi M, Cicero G, Molica S, Palazzo S, Iacopino P. Martino M, et al. Tumori. 2003 Sep-Oct;89(5):492-6. doi: 10.1177/030089160308900506. Tumori. 2003. PMID: 14870770 Clinical Trial.

6

Administration of recombinant human erythropoietin alpha before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma patients.

Martino M, Oliva E, Console G, Stelitano C, Fujo M, Messina G, Irrera G, Pucci G, Mandaglio R, Callea V, Nobile F, Iacopino P, Morabito F. Martino M, et al. Support Care Cancer. 2005 Mar;13(3):182-7. doi: 10.1007/s00520-004-0686-2. Epub 2004 Oct 6. Support Care Cancer. 2005. PMID: 15480819

7

Harvesting peripheral blood progenitor cells from healthy donors: retrospective comparison of filgrastim and lenograstim.

Martino M, Console G, Irrera G, Callea I, Condemi A, Dattola A, Messina G, Pontari A, Pucci G, Furlò G, Bresolin G, Iacopino P, Morabito F. Martino M, et al. J Clin Apher. 2005 Oct;20(3):129-36. doi: 10.1002/jca.20049. J Clin Apher. 2005. PMID: 15892086

8

Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation.

Galimberti S, Benedetti E, Morabito F, Papineschi F, Callea V, Fazzi R, Stelitano C, Andreazzoli F, Guerrini F, Ciabatti E, Martino M, Nobile F, Iacopino P, Petrini M. Galimberti S, et al. Among authors: martino m. Leuk Res. 2005 Aug;29(8):961-6. doi: 10.1016/j.leukres.2005.01.017. Leuk Res. 2005. PMID: 15978948 Clinical Trial.

9

Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantation.

Galimberti S, Benedetti E, Morabito F, Petrini I, Battolla B, Papineschi F, Fazzi R, Ciabatti E, Martino M, Cuzzola M, Console G, Iacopino P, Petrini M. Galimberti S, et al. Among authors: martino m. Leuk Res. 2006 May;30(5):529-35. doi: 10.1016/j.leukres.2005.09.004. Epub 2005 Oct 24. Leuk Res. 2006. PMID: 16249028

10

Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity setting.

Galimberti S, Benedetti E, Morabito F, Fazzi R, Pacini S, Andreazzoli F, Martino M, Iacopino P, Petrini M. Galimberti S, et al. Among authors: martino m. Transpl Immunol. 2005 Dec;15(2):173-7. doi: 10.1016/j.trim.2005.06.002. Epub 2005 Jul 25. Transpl Immunol. 2005. PMID: 16412962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,303 results

Search Page